Microsoft word - publikationen.doc

Publikationen - Auswahl der letzten 5 Jahre
Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients
with slow virologic response.
Ferenci P, Laferl H, Scherzer TM, Maieron A, Hofer H, Stauber R, Gschwantler M, Brunner H, Wenisch C, Bischof M, Strasser M, Datz C, Vogel W, Löschenberger K, Steindl-Munda P; Gastroenterology. 2010 Feb;138(2):503-12, 512.e1. Epub 2009 Nov 10 Germline mutation of the E-cadherin gene in three sibling cases with advanced gastric
cancer: clinical consequences for the other family members.
Mayrbaeurl B, Keller G, Schauer W, Burgstaller S, Czompo M, Hoebling W, Knoflach P, Duba HC, Eur J Gastroenterol Hepatol. 2010 Mar;22(3):306-10. Adalimumab for the treatment of Crohn's disease - consensus paper of the Working Group
"chronic inflammatory bowel diseases" of the Austrian Society for Gastroenterology and
Reinisch W, Haas T, Kaser A, Petritsch W, Vogelsang H, Feichtenschlager T, Novacek G, Siebert Z Gastroenterol. 2009 Apr;47(4):372-80. Epub 2009 Apr 8. German. Quantitative autonomic testing in the management of botulism.
Topakian R, Heibl C, Stieglbauer K, Dreer B, Nagl M, Knoflach P, Aichner FT. J Neurol. 2009 May;256(5):803-9. Epub 2009 Feb 25. Concomitant manifestation of pyoderma gangrenosum and colorectal carcinoma.
Bunte C, Popp-Habeler J, Mischer P, Tuppy H, Haidenthaler A, Knoflach P, Kirchgatterer A. Scand J Gastroenterol. 2008;43(6):756-8. Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with
rapid virological response.
Ferenci P, Laferl H, Scherzer TM, Gschwantler M, Maieron A, Brunner H, Stauber R, Bischof M, Bauer B, Datz C, Löschenberger K, Formann E, Staufer K, Steindl-Munda P; Austrian Hepatitis Gastroenterology. 2008 Aug;135(2):451-8. Epub 2008 May 27. The frequency of wound infections after PEG-placement and utilization of glycogel wound
dressing: a randomized controlled trial
Aschl G, Kirchgatterer A, Fleischer M, Hinterreiter M, Hubner D, Kranewitter W, Stadler B, Wien Klin Wochenschr. 2008;120(7-8):224-7. German A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination
with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3.
Ferenci P, Brunner H, Laferl H, Scherzer TM, Maieron A, Strasser M, Fischer G, Hofer H, Bischof M, Stauber R, Gschwantler M, Steindl-Munda P, Staufer K, Löschenberger K; Austrian Hepatitis Variceal hemorrhage in a patient with ulcerative colitis treated with 6-Thioguanine.
Inflamm Bowel Dis. 2008 Apr;14(4):582-3. A systematic survey evaluating 6-thioguanine-related hepatotoxicity in patients with
inflammatory bowel disease.
Teml A, Schwab M, Hommes DW, Almer S, Lukas M, Feichtenschlager T, Florin T, Seiderer J, Petritsch W, Bokemeyer B, Kreisel W, Herrlinger KR, Knoflach P, Bonaz B, Klugmann T, Herfarth Wien Klin Wochenschr. 2007;119(17-18):519-26. Use of infliximab in ulcerative colitis
Tilg H, Feichtenschlager T, Knoflach P, Petritsch W, Schöfl R, Vogelsang H, Reinisch W. Z Gastroenterol. 2007 Aug;45(8):907-11. German Long-term outcome following placement of percutaneous endoscopic gastrostomy in
younger and older patients.
Kirchgatterer A, Bunte C, Aschl G, Fritz E, Hubner D, Kranewitter W, Fleischer M, Hinterreiter M, Scand J Gastroenterol. 2007 Feb;42(2):271-6. ERCP is safe and effective in patients 80 years of age and older compared with younger
Fritz E, Kirchgatterer A, Hubner D, Aschl G, Hinterreiter M, Stadler B, Knoflach P. Gastrointest Endosc. 2006 Dec;64(6):899-905. Endoscopy in IBD. A Consensus Report of the IBD Working of the Austrian Association of
Gastroenterology and Hepatology
Petritsch W, Tillinger W, Vogelsang H, Reinisch W, Knoflach P, Tilg H. Z Gastroenterol. 2006 Nov;44(11):1183-92. German Aminosalicylates and steroids in the treatment ot chronic inflammatory bowel diseases--
consensus paper of the Working Group for Chronic Inflammatory Bowel Diseases of the
Dejaco C, Haas T, Kirchgatterer A, Miehsler W, Wenzl H, Knoflach P, Petritsch W, Vogelsang H, Z Gastroenterol. 2006 Jun;44(6):525-38; discussion 539. Review. German. 6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European
6-TG working party.
de Boer NK, Reinisch W, Teml A, van Bodegraven AA, Schwab M, Lukas M, Ochsenkühn T, Petritsch W, Knoflach P, Almer S, van der Merwe SW, Herrlinger KR, Seiderer J, Vogelsang H, Digestion. 2006;73(1):25-31. Epub 2006 Feb 21. Review. Weight loss, abdominal pain and anemia after a holiday abroad--case report of lead
Dtsch Med Wochenschr. 2005 Oct 7;130(40):2253-6. German. Lansoprazole-associated collagenous colitis: a case report.
Rammer M, Kirchgatterer A, Höbling W, Knoflach P.


The advantage of heading to the west coast of america is that 7am starts can be met with bright eyes and a bushy tail

Travelling Fellowship Report Andrew Birnie (who is very grateful for the generous funding provided by the BSDS) The advantage of heading to the west coast of America is that 7am starts can be met with bright eyes and a bushy tail. Which was fortunate, as that is the time that activities commenced on Dr Hugh Greenway’s Superficial Anatomy and Cutaneous Surgery Course. This is an intensive


EFFICACY: PetTrust™ Plus chewable tablets given orally using the recommended dose and regimen, are effective against the tissue larval stage of D. immitis for a month (30 days) after infection and, as a result, prevent the development of the adult stage. PetTrust™ Plus chewable tablets are also effective against canine ascarids ( T. canis, T. leonina ) and hookworms ( A. caninum, U. st

Copyright © 2014 Medical Pdf Articles